CLINICAL_TRIALS trial_result · 2011-08-29

Clinical Trial Update: Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST) [Phase 2]

A Phase 2 trial of nilotinib in patients with advanced gastrointestinal stromal tumors was terminated; results were posted in August 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Fox Chase Cancer Center | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: TERMINATED | Results posted: 2011-08-29